Hepato-Protective Effect of Resveratrol Against Acetaminophen-Induced Liver Injury is Associated with Inhibition of Cyp-Mediated Bioactivation and Regulation of Sirt1-P53 Signaling Pathways

Ying Wang,Yiming Jiang,Xiaomei Fan,Huasen Tan,Hang Zeng,Yongtao Wang,Pan Chen,Min Huang,Huichang Bi

DOI: https://doi.org/10.1016/j.toxlet.2015.05.001

IF: 4.271

2015-01-01

Toxicology Letters

Abstract:Resveratrol (RES) has been shown to possess many pharmacological activities including protective effect against liver damage induced by hepatotoxins. In the present study, the hepato-protective effect of RES against acetaminophen (APAP)-induced liver injury in mice and the involved mechanisms was investigated. This study clearly demonstrated that administration of RES three days before APAP treatment significantly alleviated APAP-induced hepatotoxicity, as evidenced by morphological, histopathological, and biochemical assessments such as GSH content and serum ALT/AST activity. Treatment with RES resulted in significant inhibition of CYP2E1, CYP3A11, and CYP1A2 activities, and then caused significant inhibition of the bioactivation of APAP into toxic metabolite NAPQI. Pretreatment with RES significantly reduced APAP-induced JNK activation to protect against mitochondrial injury. Additionally, RES treatment significantly induced SIRT1 and then negatively regulated p53 signaling to induce cell proliferation-associated proteins including cyclin D1, CDK4, and PCNA to promote hepatocyte proliferation. This study demonstrated that RES prevents APAP-induced hepatotoxicity by inhibition of CYP-mediated APAP bioactivation and regulation of SIRT1, p53, cyclin D1 and PCNA to facilitate liver regeneration following APAP-induced liver injury.